Amicus Therapeutics, Inc. Announces First Quarter 2012 Financial Results

Published: May 11, 2012

CRANBURY, N.J., May 10, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced financial results for the first quarter ended March 31, 2012. The Company also highlighted recent and upcoming milestones related to its pharmacological chaperone development pipeline and reiterated full-year 2012 operating expense guidance.

Back to news